LENSAR Inc (LNSR)
5.86
+0.48
(+8.92%)
USD |
NASDAQ |
Nov 04, 16:00
5.86
0.00 (0.00%)
Pre-Market: 20:00
LENSAR Gross Profit Margin (Quarterly): 53.92% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 53.92% |
| March 31, 2024 | 53.49% |
| December 31, 2023 | 42.54% |
| September 30, 2023 | 49.79% |
| June 30, 2023 | 56.29% |
| March 31, 2023 | 52.35% |
| December 31, 2022 | 63.35% |
| September 30, 2022 | 50.19% |
| June 30, 2022 | 60.86% |
| March 31, 2022 | 50.24% |
| Date | Value |
|---|---|
| December 31, 2021 | 50.17% |
| September 30, 2021 | 46.55% |
| June 30, 2021 | 56.27% |
| March 31, 2021 | 55.29% |
| December 31, 2020 | 56.31% |
| September 30, 2020 | 54.53% |
| June 30, 2020 | 38.56% |
| March 31, 2020 | 60.41% |
| December 31, 2019 | 55.14% |
| September 30, 2019 | 40.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
38.56%
Minimum
Jun 2020
63.35%
Maximum
Dec 2022
52.96%
Average
53.92%
Median
Jun 2024
Gross Profit Margin (Quarterly) Benchmarks
| Standard BioTools Inc | 51.73% |
| Ainos Inc | -- |
| Zomedica Corp | 71.15% |
| Intelligent Bio Solutions Inc | -- |
| Adagio Medical Holdings Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -39.74% |
| Return on Assets | -18.51% |
| Return on Invested Capital | -39.74% |
| Profit Margin (Quarterly) | -71.57% |
| Operating Margin (Quarterly) | -12.27% |
| Return on Net Operating Assets | -31.04% |